Toft Group Completes Executive Search for Accriva Diagnostics in San Diego, CA

Accriva

Executive search firm Toft Group has placed Dr. Mark Rubinstein, M.D. as Director, Medical Affairs at Accriva Diagnostics in San Diego, CA. Dr. Rubinstein most recently served as Senior Manager, Global Medical Affairs for Baxter Healthcare Corporation in Westlake Village, CA. He holds a M.D. from the Universidad Anahuac, Graduate School of Medicine in Mexico City, Mexico and completed his post graduate surgical residency at USC and Huntington Memorial Hospital.

About Accriva Diagnostics

Accriva Diagnostics is the result of ITC's 2013 acquisition of Accumetrics. The combined strengths in coagulation monitoring (ITC) and platelet testing (Accumetrics) have created a leading point-of-care diagnostic company. The Accriva portfolio of products represent over 40 years of leadership and expertise in hemostasis management, including the development, manufacturing and marketing of Hemochron®, InRhythm™ and ProTime® Microcoagulation systems; the VerifyNow® system for assessment of platelet reactivity; Avoximeter®CO-Oximetry systems; Tenderfoot®, Tenderlett® and Surgicutt® skin incision products. Accriva is a portfolio company of Warburg Pincus, a global private equity firm focused on growth investing.